Peter L Nara

Citado por

	Total	Desde 2020
Citas	12388	964
Índice h	54	15
Índice i10	114	20

580

290

145

435

1988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202587 143 261 341 514 559 530 541 559 564 577 414 382 380 313 305 351 323 316 327 306 289 349 358 387 355 325 294 290 200 191 177 234 204 215 147 147 16

Acceso público

Ver todo

7 artículos

0 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Jay BerzofskyChief, Vaccine Branch, CCR, NCI, NIHDirección de correo verificada de mail.nih.gov
Carlos F. Barbas IIIProfessor of Chemistry and Molecular and Cell Biology,The Scripps Research InstituteDirección de correo verificada de scripps.edu
John L SpougeSenior Investigator, National Institutes of HealthDirección de correo verificada de nih.gov
William HatchEvolution Medical CommunicationsDirección de correo verificada de evolutionmedcom.com
Micah DemboBoston Univ. (Ret.)Dirección de correo verificada de bu.edu
Nancy L. HaigwoodOregon Health & Science UniversityDirección de correo verificada de ohsu.edu
Soulaima ChamatProfessor of immunologyDirección de correo verificada de ul.edu.lb
Garth D. Ehrlich, Ph.D., F.A.A.A.S., F.A....Drexel UniversityDirección de correo verificada de drexel.edu
ParrenLeiden University Medical CenterDirección de correo verificada de lumc.nl
Stephen SharpSenior Statistician, MRC Epidemiology Unit, University of CambridgeDirección de correo verificada de mrc-epid.cam.ac.uk
Guus RimmelzwaanAlexander von Humboldt professor in Virology, University of Veterinary Medicine, Hannover, GermanyDirección de correo verificada de tiho-hannover.de
Howard E. GendelmanProfessor and Chair, Pharmacology & Experimental Neuroscience, University of Nebraska Medical CenterDirección de correo verificada de unmc.edu
TIMOTHY O'LEARYDepartment of Veterans AffairsDirección de correo verificada de va.gov
Kyoung-Jin Yoon, DVM, PhD, DACVMProfessor, College of Veterinary Medicine, Iowa State UniversityDirección de correo verificada de iastate.edu
Keyao PanSenior Postdoctoral Associate, Massachusetts Institute of TechnologyDirección de correo verificada de mit.edu
Jonathan Luke HeeneyProfessor of Comparative Pathology, University of CambridgeDirección de correo verificada de cam.ac.uk
Simon LevinProfessor of Ecology and Evolutionary Biology, Princeton UniversityDirección de correo verificada de princeton.edu
Gerald LearnRetired

Seguir

Peter L Nara

Keystone Bio Inc.

Dirección de correo verificada de keystonebio.com

infectious diseases oncology vaccines HIV


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody DR Burton, J Pyati, R Koduri, SJ Sharp, GB Thornton, PWHI Parren, ... Science 266 (5187), 1024-1027, 1994	1433	1994
Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide … MR Boyd, KR Gustafson, JB McMahon, RH Shoemaker, BR O'Keefe, ... Antimicrobial agents and chemotherapy 41 (7), 1521-1530, 1997	795	1997
In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity. CF Barbas 3rd, D Hu, N Dunlop, L Sawyer, D Cababa, RM Hendry, ... Proceedings of the National Academy of Sciences 91 (9), 3809-3813, 1994	454	1994
Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. M Girard, MP Kieny, A Pinter, F Barre-Sinoussi, P Nara, H Kolbe, ... Proceedings of the National Academy of Sciences 88 (2), 542-546, 1991	452	1991
Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro. CF Barbas 3rd, E Björling, F Chiodi, N Dunlop, D Cababa, TM Jones, ... Proceedings of the National Academy of Sciences 89 (19), 9339-9343, 1992	390	1992
Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody PL Nara, WC Hatch, NM Dunlop, WG Robey, LO Arthur, MA Gonda, ... AIDS research and human retroviruses 3 (3), 283-302, 1987	388	1987
MAP 30: a new inhibitor of HIV-1 infection and replication S Lee-Huang, PL Huang, PL Nara, HC Chen, H Kung, P Huang, ... FEBS letters 272 (1-2), 12-18, 1990	316	1990
Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees PL Nara, L Smit, N Dunlop, W Hatch, M Merges, D Waters, J Kelliher, ... Journal of virology 64 (8), 3779-3791, 1990	268	1990
HIV requires multiple gp120 molecules for CD4-mediated infection SP Layne, MJ Merges, M Dembo, JL Spouge, PL Nara Nature 346 (6281), 277-279, 1990	247	1990
The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course? S Jurriaans, B Van Gemen, GJ Weverling, D Van Strup, P Nara, ... Virology 204 (1), 223-233, 1994	246	1994
A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS D Zagury, J Bernard, R Cheynier, I Desportes, R Leonard, M Fouchard, ... Nature 332 (6166), 728-731, 1988	244	1988
Neutralization of HIV‐1: a paradox of humoral proportions PL Nara, RR Garrity, J Goudsmit The FASEB journal 5 (10), 2437-2455, 1991	241	1991
The role of the V3 loop of gp 120 in HIV infection JP Moore, PL Nara Aids 5, 21-34, 1991	229	1991
Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees EA Emini, PL Nara, WA Schleif, JA Lewis, JP Davide, DR Lee, J Kessler, ... Journal of Virology 64 (8), 3674-3678, 1990	216	1990
Refocusing neutralizing antibody response by targeted dampening of an immunodominant epitope. RR Garrity, G Rimmelzwaan, A Minassian, WP Tsai, G Lin, JJ De Jong, ... Journal of immunology (Baltimore, Md.: 1950) 159 (1), 279-289, 1997	214	1997
Immunohistochemical localization of human and simian immunodeficiency viral antigens in fixed tissue sections. JM Ward, TJ O'Leary, GB Baskin, R Benveniste, CA Harris, PL Nara, ... The American journal of pathology 127 (2), 199, 1987	209	1987
Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicity JD Lifson, KM Hwang, PL Nara, B Fraser, M Padgett, NM Dunlop, ... Science 241 (4866), 712-716, 1988	206	1988
Quantitative infectivity assay for HIV-1 and-2 PL Nara, PJ Fischinger Nature 332 (6163), 469-470, 1988	200	1988
Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells PN Fultz, P Nara, F Barre-Sinoussi, A Chaput, ML Greenberg, ... Science 256 (5064), 1687-1690, 1992	189	1992
Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: granulocyte-macrophage colony-stimulating factor and TNF-alpha synergize with IL-12 … JD Ahlers, N Dunlop, DW Alling, PL Nara, JA Berzofsky Journal of immunology (Baltimore, Md.: 1950) 158 (8), 3947-3958, 1997	179	1997

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores